INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...
Eli Lilly and Company (NYSE:LLY – Free Report) – Investment analysts at Zacks Research boosted their Q2 2025 earnings per share estimates for shares of Eli Lilly and Company in a research note issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback